Bristol-Myers inks 10-year CMO deal; AstraZeneca picks Dotmatics for virtual neuro biz;

> Bristol-Myers Squibb ($BMY) has signed a 10-year deal with CMO Samsung BioLogics, tasking the South Korean company with producing a cancer drug. More

> AstraZeneca ($AZN) has recruited another contractor to its nearly all-outsourced neuroscience unit, this time linking up with clinical IT outfit Dotmatics. Story

> Lonza is phasing out a troubled Massachusetts manufacturing plant, part of its efforts to cut costs and trim 250 jobs. Article

> Aesica has appointed a new chief operating officer, tasking Chris Gowland with overseeing all of its manufacturing sites. Report